Lineage Cell Therapeutics Inc (LCTX)

Precedente Chiudi:

$1.06

Aprire:

$1.08

Volume 24 ore:

1.36M

Capitalizzazione di mercato:

$203.90M

Reddito:

$8.95M

Utile/perdita netta:

$-21.49M

Rapporto P/E:

-8.3077

EPS:

-0.13

Flusso di cassa netto:

$-29.24M

1 W Prestazione:

-7.69%

1M Prestazione:

-16.28%

6M Prestazione:

+13.68%

1 anno Prestazione:

-21.74%

Intervallo 1D:

$1.0201

$1.09

Portata 52W:

$0.8414

$1.61

Lineage Cell Therapeutics Inc Stock (LCTX) Company Profile

Nome

Lineage Cell Therapeutics Inc

Settore

Healthcare (1209)

Industria

Biotechnology (699)

Telefono

510-871-4188

Indirizzo

2173 Salk Avenue, Suite 200, Carlsbad, CA

Dipendente

76

Cinguettio

@LineageCell

Prossima data di guadagno

2024-06-11

Ultimi documenti SEC

LCTX's Discussions on Twitter

Lineage Cell Therapeutics Inc Borsa (LCTX) Ultime notizie

This trade activity should not be overlooked: Lineage Cell Therapeutics Inc (LCTX) – Sete News - SETE News

SETE News

Cell Therapy Market size is set to grow by USD 31041.49 million from 2023-2027, limitations in traditional organ ... - The Malaysian Reserve

The Malaysian Reserve

Cell Therapy Market size is set to grow by USD 31041.49 million from 2023-2027, limitations in traditional organ ... - Lelezard

Lelezard

LCTX’s Market Whiplash: 0.00% YTD Decline, -16.15% Plunge in 30 Days - The InvestChronicle

The InvestChronicle

Financial Analysis: Lineage Cell Therapeutics Inc (LCTX)'s Ratios Unveil Key Insights – DWinneX - The Dwinnex

The Dwinnex

Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) Forecasted to Post FY2028 Earnings of $0.16 Per Share - MarketBeat

MarketBeat

Lineage Cell Therapeutics Inc Azioni (LCTX) Dati Finanziari

Lineage Cell Therapeutics Inc (LCTX) Reddito 2024

Lineage Cell Therapeutics Inc (LCTX) Reddito netto 2024

Lineage Cell Therapeutics Inc (LCTX) Flusso di cassa 2024

Lineage Cell Therapeutics Inc (LCTX) Utile per azione 2024